[Hypolipemic and antiatherogenic effects of 2',4' dichlorobenzoate of 7-gamma(beta-hydroxypropyl)-theophylline (HME2)].
Wójcicki
J
J
Samochowiec
L
L
Bartłomowicz
B
B
Kadłubowska
D
D
Marona
H
H
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D006949:Hyperlipidemias / Q000517:prevention & control*; D000960:Hypolipidemic Agents; D008055:Lipids / Q000097:blood*; D008297:Male; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology
D000960:Hypolipidemic Agents; D008055:Lipids; C059339:7-gamma-(beta-hydroxypropyl)theophylline 2',4'-dichlorobenzoate; D013806:Theophylline
Działanie hipolipemiczne i przeciwmiazdzycowe 2',4'-dichlorobenzoesanu 7-gamma-(beta-hydroksypropylo)-teofiliny (HME2).